EnzymoCore

Company Overview

Snapshot

Founded in May 2007 by Sobhi Basheer, EnzymoCore operates with 1–10 employees. The company has secured $16.88 million in total capital across 16 funding rounds from 4 investors. In January 2019, EnzymoCore received a grant from EU Horizon 2020 and Israel Innovation Authority, highlighting its continued focus on leveraging strategic partnerships for research and development.

Business overview

EnzymoCore specializes in developing immobilized enzyme-based biocatalysts for the production of second- and third-generation biodiesel fuels, adhering to ASTM and EN standards. Its core technology enables the conversion of low-grade feedstocks, such as waste fish and algal oils, into high-quality omega-3 concentrates and biodiesel. This innovation aims to reduce biodiesel production costs and enhance environmental sustainability. The company operates within the Energy Tech sector, serving industries focused on renewable energy, alternative fuels, and circular economy solutions by transforming waste into valuable bio-products.

Strategic signal

In November 2014, Appalachian Biofuels announced plans to construct a plant utilizing TransBiodiesel (now EnzymoCore) enzymes. This development signals strong commercial validation for EnzymoCore's proprietary enzyme technology, demonstrating its potential for industrial-scale application in the bio-energy sector and reinforcing its role in advancing sustainable fuel production.

Company Intelligence Q&A

What is EnzymoCore's primary focus?

EnzymoCore specializes in developing immobilized enzyme-based biocatalysts to produce second- and third-generation biodiesel fuels, meeting ASTM and EN standards, and converting low-grade feedstocks into high-quality omega-3 concentrates and biodiesel.

Who founded EnzymoCore?

EnzymoCore was founded by Sobhi Basheer in May 2007.

When did EnzymoCore receive a grant from EU Horizon 2020 and Israel Innovation Authority?

EnzymoCore received a grant from EU Horizon 2020 and Israel Innovation Authority in January 2019.

Has EnzymoCore's technology been adopted commercially?

Yes, in November 2014, Appalachian Biofuels announced its intention to build a plant utilizing TransBiodiesel (now EnzymoCore) enzymes, indicating commercial adoption of the technology.

What was a notable early investment in EnzymoCore?

In October 2008, AAF Group invested in EnzymoCore during its A Round funding, as reported by Globes. This investment was a significant early backing for the company.